Peregrine Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$35.53 - $43.38 $196,161 - $239,500	5,521 Added 3.08%	184,695 $7.54 Million
Q4 2022 Jan 10, 2023	BUY	$38.19 - $57.45 $1.1 Million - $1.65 Million	28,712 Added 19.08%	179,174 $6.92 Million
Q3 2022 Oct 26, 2022	BUY	$51.24 - $58.89 $991,084 - $1.14 Million	19,342 Added 14.75%	150,462 $8 Million
Q2 2022 Jul 20, 2022	SELL	$51.49 - $81.64 $5,612 - $8,898	-109 Reduced 0.08%	131,120 $7.64 Million
Q1 2022 Apr 27, 2022	SELL	$60.03 - $76.49 $2.63 Million - $3.35 Million	-43,782 Reduced 25.02%	131,229 $10 Million
Q4 2021 Jan 31, 2022	BUY	$47.97 - $62.21 $962,805 - $1.25 Million	20,071 Added 12.95%	175,011 $10.5 Million
Q3 2021 Nov 02, 2021	SELL	$54.64 - $61.3 $1.66 Million - $1.87 Million	-30,435 Reduced 16.42%	154,940 $8.68 Million
Q2 2021 Aug 03, 2021	SELL	$59.18 - $69.99 $488,235 - $577,417	-8,250 Reduced 4.26%	185,375 $11.2 Million
Q1 2021 May 11, 2021	SELL	$59.31 - $78.82 $1.61 Million - $2.14 Million	-27,097 Reduced 12.28%	193,625 $13.6 Million
Q4 2020 Jan 19, 2021	SELL	$50.47 - $66.26 $1.01 Million - $1.32 Million	-19,974 Reduced 8.3%	220,722 $13.2 Million
Q3 2020 Oct 20, 2020	SELL	$51.97 - $63.0 $2.71 Million - $3.29 Million	-52,202 Reduced 17.82%	240,696 $14.5 Million
Q2 2020 Jul 30, 2020	SELL	$30.8 - $52.47 $1.31 Million - $2.24 Million	-42,621 Reduced 12.7%	292,898 $15.4 Million
Q1 2020 Apr 17, 2020	BUY	$28.4 - $50.7 $12,978 - $23,169	457 Added 0.14%	335,519 $11.2 Million
Q4 2019 Jan 16, 2020	SELL	$36.31 - $46.83 $141,681 - $182,730	-3,902 Reduced 1.15%	335,062 $15.2 Million
Q3 2019 Oct 16, 2019	BUY	$35.66 - $44.99 $1.43 Million - $1.81 Million	40,203 Added 13.46%	338,964 $12.9 Million
Q2 2019 Jul 18, 2019	BUY	$36.57 - $47.97 $2.07 Million - $2.72 Million	56,733 Added 23.44%	298,761 $0
Q1 2019 Apr 12, 2019	BUY	$36.47 - $42.17 $1.49 Million - $1.72 Million	40,889 Added 20.33%	242,028 $0
Q4 2018 Jan 17, 2019	SELL	$41.31 - $52.16 $975,246 - $1.23 Million	-23,608 Reduced 10.5%	201,139 $8.65 Million
Q3 2018 Oct 18, 2018	SELL	$32.85 - $52.0 $1.51 Million - $2.38 Million	-45,826 Reduced 16.94%	224,747 $0
Q2 2018 Jul 12, 2018	SELL	$27.5 - $39.8 $1.53 Million - $2.21 Million	-55,483 Reduced 17.02%	270,573 $0
Q1 2018 Apr 16, 2018	SELL	$29.98 - $46.35 $1.22 Million - $1.88 Million	-40,547 Reduced 11.06%	326,056 $0
Q4 2017 Jan 24, 2018	SELL	$31.85 - $46.95 $1.2 Million - $1.76 Million	-37,538 Reduced 9.29%	366,603 $0
Q3 2017 Oct 25, 2017	BUY	$35.7 - $39.5 $14.4 Million - $16 Million	404,141	404,141 $0

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$152 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$101 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$94.2 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$38.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$37.6 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account